This bipartisan, commonsense legislation would cut red tape for emerging biotechnology companies so they can focus their resources on the critical research and development that will provide innovative treatments and save lives.
Editor's note · Context
Gary Peters advocates for legislation to reduce regulatory burdens on biotech firms.
Share & report
More from Gary Peters
Senator Gary Peters and I introduced the AI Leadership Training Act to create an AI training program for Federal supervisors and management officials.
Mr. President, I appreciate my colleague's commitment to empowering the legislative branch of government. We have worked together on a bill to rein in Presidential abuse of emergency powers. I hope we can get that across the finish line…
ENSURING A TRUSTWORTHY GOVERNMENT: EXAMINING THE NATIONAL SECURITY RISKS OF REPLACING NONPARTISAN CIVIL SERVANTS WITH POLITICAL APPOINTEES
Mr. Speaker, I thank the gentleman for yielding. Mr. Speaker, I rise today to strongly oppose efforts to repeal the waste emissions charge, commonly known as the methane fee, which is a commonsense measure that benefits American industry…





